1-4 of 4
R. Tabrizi
Close
Sort by
Journal Articles

Cord Blood Transplantation after Non Myeloablative Conditioning (Minneapolis Protocol): Impact on Transplant Outcomes in 112 Adults with Hematologic Malignancy. A French Multicentric Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and Eurocord.

B. Rio, D. Blaise, M. Renaud, M. Uzunov, J.H. Bourhis, P. Ceballos, S. Maury, C.E. Bulabois, L. Fouillard, E. Deconinck, N. Dhedin, A. Sirvent, M. Michallet, N. Contentin, A. Huynh, A. Buzyn, S. Francois, R. Tabrizi, I. Yakoub-Agha, P. Chevalier, T. de Revel, S. Lapusan, F. Garnier, K. Boudjedir, Eliane Gluckman, V. Rocha
Journal: Blood
Blood (2007) 110 (11): 2029.
https://doi.org/10.1182/blood.V110.11.2029.2029
Published: 2007
Journal Articles

Donor Response to G-CSF Is the Best Predictive Factor of Extensive Chronic Graft-Versus-Host Disease after Non Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation.

N. Dhedin, MD, T. Prebet, MD, D. Rea, MD, PHD, M.L. Tanguy, M. Kuentz, MD, N. Piard, MD, F. Norol, MD, PHD, J.P. Jouet, MD, Ja Rubeil, MD, R. Tabrizi, MD, B. Rio, MD, B. Lioure, MD, P. Tiberghien, MD, PHD, J.H. Bourrhis, MD, A. Sirvent, MD, P. Bordigoni, MD, D. Blaise, MD, Mauricette Michallet, MD, PHD, J.P. Vernant, MD
Journal: Blood
Blood (2007) 110 (11): 2188.
https://doi.org/10.1182/blood.V110.11.2188.2188
Published: 2007
Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) in Waldenström Macroglobulinemia (Wm), Update of the French Experience in 54 Cases.

N. Dhedin, MD, R. Tabrizi, MD, P.E. Bulabois, MD, S. Le Gouill, MD, V. Coiteux, MD, C. Dartigeas, MD, M. Robin, MD, A. Huynh, MD, F. Larosa, MD, V. Cacheux, MD, A. Garnier, MD, P. Morel, MD, M. Kuentz, MD, B. Dreyfus, MD, B. Desablens, MD, G. Guillerm, MD, B. Pignon, MD, B. Rio, MD, K. Bilger, MD, A. Cabrespine, MD, M. Uzunov, MD, Jacques-Olivier Bay, MD, PHD, V. Leblond, MD, O. Tournihac, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3015.
https://doi.org/10.1182/blood.V110.11.3015.3015
Published: 2007
Journal Articles

Sustained Effect of First Line Sequential Therapy with Intensive Consolidation Chemotherapy and Allogeneic Hematopoietic Stem Cell Transplantation (ASCT) after Reduced Intensity Conditioning (RIC) for Patients with Acute Myeloblastic Leukemia (AML) in First Complete Remission (CR1).

Didier Blaise, MD, R. Tabrizi, MD, C. Faucher, MD, Mohamad Mohty, MD, J.O. Bay, MD, J.M. Boiron, MD, G. Marit, MD, S. Furst, MD, A.M. Stoppa, MD, A. Charbonnier, MD, T. Prebet, MD, C. Chabannon, MD, N. Vey
Journal: Blood
Blood (2006) 108 (11): 3000.
https://doi.org/10.1182/blood.V108.11.3000.3000
Published: 2006